Detalles de la búsqueda
1.
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Br J Dermatol
; 190(6): 836-845, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470171
2.
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study.
Am J Clin Dermatol
; 24(4): 623-635, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184828
3.
Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS).
Dermatol Ther (Heidelb)
; 12(4): 921-931, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286612
Resultados
1 -
3
de 3
1
Próxima >
>>